Page last updated: 2024-10-26

dipyridamole and Biliary Calculi

dipyridamole has been researched along with Biliary Calculi in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hagège, H1
Fonpeydie, D1
Ink, O1
Buffet, C1
Fritsch, J1
Choury, A1
Levillain, P1
Etienne, JP1
Moesch, C1
Sautereau, D1
Gainant, A1
Pillegand, B1

Other Studies

2 other studies available for dipyridamole and Biliary Calculi

ArticleYear
Iatrogenic gallstone with dipyridamole.
    Journal of hepatology, 1994, Volume: 21, Issue:4

    Topics: Aged; Aged, 80 and over; Dipyridamole; Female; Gallstones; Humans; Iatrogenic Disease

1994
Biliary drug lithiasis: dipyridamole gallstones.
    Lancet (London, England), 1992, Nov-28, Volume: 340, Issue:8831

    Topics: Aged; Aged, 80 and over; Dipyridamole; Female; Gallstones; Humans; Male; Spectrophotometry, Infrared

1992